July 2026 - Multibillion-dollar trading event anticipated as major indices undergo quarterly and semi-annual reviews.

July 2026 - Portfolio manager Nick Kelly discusses WMA's strategy to bridge discount and navigate alternative asset market dynamics.

ReNerve (ASX: RNV) is advancing its transition to a commercial medical device company, with CEO Dr Julien Chick highlighting ...

July 2026 - Drilling beneath existing oxide resource reveals substantial sulphide mineralisation in South Australia.

July 2026 - ASX-listed company reports significant advancements in permitting, project engineering, and team expansion for ...

July 2026 - Managing Director Tony Greenaway outlines exploration progress and upcoming catalysts across Brazil and Namibia.

July 2026 - Initial 2026 drill campaign expands Manyingee North mineralisation strike length and confirms further prospects.

Australia’s reporting season begins next week, with analysts anticipating a challenging period for corporate profitability.

INOVIQ (ASX: IIQ) is advancing the commercialisation of its exosome-based ovarian cancer blood test, with CEO Dr Leearne ...

July 2026 - Strong employment data lifts bond yields and the Australian dollar as investors reassess RBA expectations ...

July 2026 - The action concerns alleged contraventions related to button battery products and a breach of a 2023 undertaking.

The rebrand to Altoro Metals reflects the company’s evolution and its expanded focus across a portfolio of zinc and ...